GSK-294

SynDRA canonical compound SYN0041169 — structure-anchored drug synonym record

Clinical phase	Phase 1
Primary target(s)	APP
Mechanism of action	beta amyloid inhibitor
Indication	alzheimer's disease
Disease area	neurology/psychiatry

Cross-references

PubChem CID: 92136018
ChEMBL: CHEMBL6068552

Synonyms

Gsk3039294
GSK-3039294
GSK294
amyloid P-IN-1
GSK3039294
amyloid P-IN-1?
orb1308653
SCHEMBL17223624
C30H44N2O14
MFCD30489728
AKOS032945090
amyloid P-IN-1(GSK3039294)?
CS-5916
AC-38424
DA-61037
HY-19771
MS-30991
T14283

Look up GSK-294 in the interactive SynDRA portal →